Experience has demonstrated that the success of a clinical trial depends on the people conducting the trial. Thus, we do our best to have the highest contribution to your clinical development project.
Our highly motivated Clinical Research Associates (CRAs) are continuously trained so as to professionally manage the participating investigational sites and ensure the quality compliance of your trial.
Their advanced clinical trial monitoring skills along with the continuous training they receive on ICH-GCP updates, local and international regulatory updates, AE/SAE Reporting and Informed Consent procedures allow them not only to validate data integrity and monitor recruitment, eligibility and consent but to also ensure clinical study's overall reliability and excellence.
Risk Based Monitoring
In CORONIS we share your concern for the challenges that your clinical development journey might face. We are here to help you utilize the time and the technology tools offered. The EDC technologies, with real-time access to data, have contributed to the development of optimized methods of conducting clinical studies.
The risk-based monitoring (RBM) approach in clinical trials, has been proven to provide as equally qualitative data as standard monitoring, reducing significantly the costs at the same time.
After thoroughly mapping your clinical trial's processes, specifications, and requirements, the risk-based monitoring plan is being designed by our clinical project managers in collaboration with our scientific advisory team, to holistically cover every monitoring aspect of the project. This is being achieved by utilizing our clinical team's expertise and leveraging the advancements that technology has to offer.